Non-curative treatment of patients with oral tongue squamous-cell carcinoma

[1]  V. Paleri,et al.  Palliative radiotherapy for locally advanced non-metastatic head and neck cancer: A systematic review. , 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[2]  A. Mäkitie,et al.  End-of-life care pathway of head and neck cancer patients: single-institution experience , 2018, European Archives of Oto-Rhino-Laryngology.

[3]  Antti Mäkitie,et al.  Improved outcomes with oral tongue squamous cell carcinoma in Finland , 2017, Head & neck.

[4]  Kai-xin Li,et al.  Dosimetric and clinical factors for predicting acute radiation oral mucositis in locally advanced nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy with concurrent chemotherapy , 2017 .

[5]  K. Clark.  Care at the Very End-of-Life: Dying Cancer Patients and Their Chosen Family’s Needs , 2017, Cancers.

[6]  K. Ah-See,et al.  Palliative and supportive care in head and neck cancer: United Kingdom National Multidisciplinary Guidelines , 2016, The Journal of Laryngology & Otology.

[7]  B. Judson,et al.  Refusal of postoperative radiotherapy and its association with survival in head and neck cancer. , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[8]  N. Lee,et al.  Palliative head and neck radiotherapy with the RTOG 8502 regimen for incurable primary or metastatic cancers. , 2015, Oral oncology.

[9]  Kevin J. Harrington,et al.  The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence , 2015, Nature Reviews Cancer.

[10]  S. Phillips,et al.  The Refusal of Palliative Radiation in Metastatic Non-Small Cell Lung Cancer and Its Prognostic Implications. , 2015, Journal of pain and symptom management.

[11]  K. Kaneko,et al.  Peritonitis related to percutaneous endoscopic gastrostomy using the direct method for cancer patients , 2015, Surgical Endoscopy.

[12]  A. Rahnemai-azar,et al.  Percutaneous endoscopic gastrostomy: indications, technique, complications and management. , 2014, World journal of gastroenterology.

[13]  S. Rogers,et al.  Place and time of death in patients treated with palliative intent for oral cancer. , 2014, British Journal of Oral and Maxillofacial Surgery.

[14]  P. Bradley,et al.  The role of surgery in the palliation of head and neck cancer , 2014, Current opinion in otolaryngology & head and neck surgery.

[15]  L. Howie,et al.  Early palliative care in cancer treatment: rationale, evidence and clinical implications , 2013, Therapeutic advances in medical oncology.

[16]  C. Mathers,et al.  GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer , 2013 .

[17]  D. Kraus,et al.  Percutaneous endoscopic gastrostomy in oropharyngeal cancer patients treated with intensity‐modulated radiotherapy with concurrent chemotherapy , 2012, Cancer.

[18]  L. Kowalski,et al.  Recurrent Oral Cancer: Current and Emerging Therapeutic Approaches , 2012, Front. Pharmacol..

[19]  E. Bruera,et al.  Palliative care in advanced cancer patients: how and when? , 2012, The Oncologist.

[20]  C. Earle,et al.  The effect on survival of continuing chemotherapy to near death , 2011, BMC palliative care.

[21]  J. Pruyn,et al.  Survival of patients with palliative head and neck cancer , 2011, Head & neck.

[22]  Kelvin K. W. Chan,et al.  Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy. , 2011, The Cochrane database of systematic reviews.

[23]  W. Tierney,et al.  Prophylactic PEG placement in head and neck cancer: how many feeding tubes are unused (and unnecessary)? , 2011, World journal of gastroenterology.

[24]  I. Higginson,et al.  What Is the Evidence That Palliative Care Teams Improve Outcomes for Cancer Patients and Their Families? , 2010, Cancer journal.

[25]  F. Bray,et al.  Trends in the survival of patients diagnosed with cancers of the lip, oral cavity, and pharynx in the Nordic countries 1964–2003 followed up to the end of 2006 , 2010, Acta oncologica.

[26]  C. Bokemeyer,et al.  Platinum-based chemotherapy plus cetuximab in head and neck cancer. , 2008, The New England journal of medicine.

[27]  T. Gorlia,et al.  Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. , 2007, The New England journal of medicine.

[28]  A. Mäkitie,et al.  Oral tongue carcinoma and its treatment in Finland , 2007, European Archives of Oto-Rhino-Laryngology.

[29]  F. Caponigro,et al.  Docetaxel and cisplatin in locally advanced or metastatic squamous-cell carcinoma of the head and neck: a phase II study of the Southern Italy Cooperative Oncology Group (SICOG). , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.